Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 3
1 (100.0%)Perindopril Amlodipine for the Treatment of Hypertension
Phase 3
Completed
- Conditions
- Essential Hypertension
- Interventions
- First Posted Date
- 2012-03-19
- Last Posted Date
- 2015-09-28
- Lead Sponsor
- Symplmed Pharmaceuticals LLC
- Target Recruit Count
- 837
- Registration Number
- NCT01556997
News
No news found